Tag: whole genome and exome sequencing market drivers

  • 2024 Whole Genome And Exome Sequencing Market Summary: 5 Key Findings

    2024 Whole Genome And Exome Sequencing Market Summary: 5 Key Findings

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What is the Expected Growth Rate of the Whole Genome And Exome Sequencing Market from 2024 to 2033?

    The whole genome and exome sequencing market will increase from $1.61 billion in 2023 to $2.02 billion in 2024, with a CAGR of 25.5%. Key drivers include decreasing sequencing costs and the rise in genetic disorders.

    The whole genome and exome sequencing market is expected to see strong growth, reaching $4.91 billion in 2028 with a CAGR of 24.8%. Growth factors include population genomics initiatives, precision medicine demand, single-cell sequencing advancements, non-invasive prenatal testing expansion, and rare disease research. Trends include clinical adoption, sequencing technology advancements, population-scale studies, AI and ML integration, and oncology applications.

    Claim Your Free Sample of the Global Whole Genome And Exome Sequencing Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=13957&type=smp

    What Key Factors Are Fueling the Growth of the Whole Genome And Exome Sequencing Market?

    The growing demand for personalized medicine is expected to enhance the whole genome and exome sequencing market. Personalized medicine tailors healthcare to individual characteristics, considering genetics and lifestyle. Whole genome and exome sequencing provides comprehensive genetic analysis for tailored interventions. In October 2022, the Personalized Medicine Coalition projected over 75,000 genetic testing products and 300 personalized medicines in 2022. The FDA approved 37 new molecular entities that year, with approximately 34% classified as personalized. Thus, the rising demand for personalized medicine is driving the whole genome and exome sequencing market.

    What Are the Major Segments of the Whole Genome And Exome Sequencing Market?

    1) By Product Type: Kits, Instruments

    2) By Workflow: Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES)

    3) By Applications: Diagnostics, Cancer, Monogenic Disorders, Diabetes, Drug Discovery And Development, Personalized Medicine, Agriculture And Animal Research, Other Applications

    4) By End user: Research Center, Academic And Government Institutions, Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Other End Users

    What New Trends Are Transforming the Whole Genome And Exome Sequencing Market?

    Companies in the whole genome and exome sequencing markets are focusing on advanced technological solutions, like ultra-fast NGS analysis, to gain a competitive advantage. This innovation allows for exceptionally rapid processing of NGS data, cutting down the time needed for genomic analysis. For example, in January 2023, QIAGEN Digital Insights introduced an ultra-fast NGS analysis platform that can process a whole genome in just 25 minutes for $1 in cloud computing costs. This technological breakthrough enhances the speed and accessibility of genomic data analysis, which is crucial for personalized medicine.

    Order Now for Fast Delivery of Your Whole Genome And Exome Sequencing Market Report!

    https://www.thebusinessresearchcompany.com/report/whole-genome-and-exome-sequencing-global-market-report

    Which Regions Are Driving Growth in the Whole Genome And Exome Sequencing Market?

    North America was the largest region in the whole genome and exome sequencing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the whole genome and exome sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    The Whole Genome And Exome Sequencing Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the whole genome and exome sequencing market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Whole Genome And Exome Sequencing Market Include

    1. Whole Genome And Exome Sequencing Market Executive Summary

    2. Whole Genome And Exome Sequencing Market Segments

    3. Whole Genome And Exome Sequencing Market Size And Template Market Growth Rate

    4. Key Whole Genome And Exome Sequencing Market Trends

    5. Major Whole Genome And Exome Sequencing Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Whole Genome And Exome Sequencing Market

    26. Top Whole Genome And Exome Sequencing Companies

    27. Whole Genome And Exome Sequencing Market Opportunities And Strategies

    28. Whole Genome And Exome Sequencing Market, Conclusions And Recommendations

    29. Appendix

    Discover Related Reports by The Business Research Company:

    NGS-Based RNA-Sequencing Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report

    Prenatal DNA Sequencing Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/prenatal-dna-sequencing-global-market-report

    Whole Exome Sequencing Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/whole-exome-sequencing-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Global Whole Genome And Exome Sequencing Market Key Insights 2024-2033

    Global Whole Genome And Exome Sequencing Market Key Insights 2024-2033

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    According to The Business Research Company’s Whole Genome And Exome Sequencing Global Market Report 2024, the template market is expected to show promising growth in the forecast period.

    The whole genome and exome sequencing market has witnessed exponential growth, driven by significant factors in both historic and forecast periods:

    • Historic Growth: Market size grew from $1.61 billion in 2023 to $2.02 billion in 2024, with a CAGR of 25.5%. Key drivers included:
      • Decreasing sequencing costs
      • Rise in genetic disorders
      • Clinical applications
      • Advancements in bioinformatics
      • Expansion of genomic data repositories
    • Forecast Growth: Expected to reach $4.91 billion by 2028, growing at a CAGR of 24.8%. Factors contributing to growth include:
      • Population genomics initiatives
      • Demand for precision medicine
      • Advancements in single-cell sequencing
      • Expansion of non-invasive prenatal testing (NIPT)
      • Application in rare disease research

    View More On The Whole Genome And Exome Sequencing Market Report 2024 – https://www.thebusinessresearchcompany.com/report/whole-genome-and-exome-sequencing-global-market-report

    The Role of Personalized Medicine in Market Expansion

    The surge in demand for personalized medicine is a key growth driver for the whole genome and exome sequencing market:

    • Personalized Medicine: Tailors healthcare interventions based on individual genetics, environment, and lifestyle.
    • Market Impact: Over 75,000 genetic testing products and 300 personalized medicines expected by 2022.
    • FDA Approvals: Significant portion of new molecular entities (NMEs) classified as personalized, driving market growth.

    Leading Companies Shaping the Market

    Major players driving innovation and market expansion include:

    • Siemens AG
    • Hoffmann-La Roche Ltd.
    • Thermo Fisher Scientific Inc.
    • Cytiva (Danaher Corporation)
    • Illumina Inc.
    • Agilent Technologies Inc.
    • Eurofins Scientific SE
    • Canon Medical Systems Corporation
    • Bio-Rad Laboratories Inc.
    • QIAGEN N.V

    Technological Innovations Driving Market Competitiveness

    Innovations such as ultra-fast NGS solutions are transforming the landscape of whole genome and exome sequencing:

    • Ultra-Fast NGS: QIAGEN launched a platform processing whole genomes in 25 minutes for $1 in cloud computing costs, enhancing efficiency and scalability.
    • Market Significance: Accelerates genomic data analysis, facilitating rapid decision-making and adoption of personalized medicine.

    Strategic Acquisitions and Market Influence

    Strategic moves by industry leaders, like QIAGEN’s acquisition of Verogen, strengthen market capabilities:

    • QIAGEN’s Acquisition: Enhances capabilities in human ID and forensics, bolstering leadership in NGS tools and services.
    • Market Impact: Broadens solution offerings, potentially influencing market dynamics and competitiveness.

    Market Segmentation

    The whole genome and exome sequencing market is segmented by:

    1. Product Type: Kits, Instruments
    2. Workflow: Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES)
    3. Applications: Diagnostics, Cancer, Monogenic Disorders, Diabetes, Drug Discovery and Development, Personalized Medicine, Agriculture and Animal Research, Other Applications
    4. End-User: Research Centers, Academic and Government Institutions, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, Other End Users

    Regional Insights

    • North America: Largest market in 2023, driven by technological advancements and healthcare infrastructure.
    • Asia-Pacific: Fastest-growing region, expected to witness significant expansion due to rising healthcare investments and genetic research initiatives.

    Conclusion

    The whole genome and exome sequencing market is poised for exponential growth, fueled by advancements in technology, rising demand for personalized medicine, and strategic industry initiatives. With innovations in sequencing technologies and expanding applications across diverse sectors, the market is set to play a pivotal role in healthcare advancements globally. As regions like Asia-Pacific emerge as key growth centers, the landscape of genomic research and personalized healthcare is expected to evolve rapidly, offering new opportunities for market players and stakeholders alike.

    Request A Sample Of The Global Whole Genome And Exome Sequencing Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=13957&type=smp